Partner Jim Abbott is quoted and the Firm is mentioned in a Pharmawire article on the potential acquisition of Talecris by a company from another industry.

June 18, 2009
Pharmawire

Jim Abbott comments on the difficulty of small companies like potential buyer Octapharma to obtain external financing.